(Q21260307)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708834%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Stephanie Warnez

1

Stephanie

Warnez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708834%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

English

0 references

publication date

2014

0 references

7 April 2014

3 references

17 September 2019

25 January 2021

27 October 2022

4 references

17 September 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708834%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

25 January 2021

27 October 2022

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708834%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

1

0 references

page(s)

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708834%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.0 Generic

13 June 2020

copyright license

3 references

17 September 2019

25 January 2021

Clozapine versus other atypical antipsychotics for schizophrenia

27 October 2022

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-Generation Versus Second-Generation Medications

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Clozapine versus typical neuroleptic medication for schizophrenia

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Clozapine prescribing in a Canadian outpatient population.

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

The psychopharmacology algorithm project at the Harvard South Shore Program: an update on schizophrenia

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Clozapine: key discussion points for prescribers

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Clozapine: balancing safety with superior antipsychotic efficacy

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Comparative effectiveness of atypical antipsychotics in schizophrenia: what have real-world trials taught us?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Choice of randomization to clozapine versus other second generation antipsychotics in the CATIE schizophrenia trial

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

A systematic review of the evidence of clozapine's anti-aggressive effects.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

The European Psychiatric Association (EPA) guidance on suicide treatment and prevention.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Time to treatment response in first-episode schizophrenia: should acute treatment trials last several months?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Managing suicide risk in patients with schizophrenia

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Results of phase 3 of the CATIE schizophrenia trial

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Real-world antipsychotic treatment practices

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

The history of clozapine and its emergence in the US market: a review and analysis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Practice guideline for the treatment of patients with schizophrenia, second edition.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

A Dutch guideline for the use of clozapine

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Clozapine: a distinct, poorly understood and under-used molecule

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Utilization and costs of antipsychotic agents: a Canadian population-based study, 1996-2006.

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

Comparison of clozapine use in Maryland and in Victoria, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

Underprescribing of clozapine and unexplained variation in use across hospitals and regions in the Canadian province of Québec

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

Clozapine as a first treatment for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

Early use of clozapine for poorly responding first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

Optimizing early prediction for antipsychotic response in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

Early Prediction of Antipsychotic Response in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

Is psychiatry ignoring suicide? The case for clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

Development of an outpatient pharmacist-managed clozapine clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-102

Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs Chlorpromazine

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

Clozapine's effectiveness for patients in state hospitals: results from a randomized trial.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3999500

U.S. national trends in the use of antipsychotics during office visits, 1998-2002

29 November 2018

1 reference

12 December 2020

Optimizing clozapine treatment

1 reference

12 December 2020

The pharmacoepidemiology of antipsychotics for adults with schizophrenia in Canada, 2005 to 2009

1 reference

12 December 2020

Clozapine use in Australia

1 reference

12 December 2020

Optimising treatment of refractory schizophrenia

1 reference

12 December 2020

Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-244X-14-102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708834%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

13 June 2020

1003496360

0 references

Fatcat ID

release_ctzu3bs5nffz7e7pya6yb6lo74

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708834%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

PubMed publication ID

24708834

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708834%20AND%20SRC:MED&resulttype=core&format=json